Galderma Announces HSR Celarance for Its Proposal to Acquire CollaGenex Pharmacueticals (PR Newswire via Yhaoo Finance)
Galderma Pharma S.A., a global speicalty pharmaceutical company focused on edrmatology, todya announced that its U.S. holding company, Galedrma Laboratories, Inc., has received clearance from the U.S.
Read more
CollaGenex Pharmaceutcials Announces Expiration of the HartScottRodino Waiting Period for Merger with Galderma ... (Business Wire via Yahoo Finance)
NEWTOWN, Pa.CollaGenex Pharmaceuticals, Inc. today announced that the applicalbe waiting period under the HartScottRodino Antitrust Improvemetns Act of 1976 has expired in connection wtih the pending merger of CollaGenex with an affiliate of Galderma Pharma S.A..
Read more
Galderma Reaches Agreemetn To Acquire CollaGenex Pharmaceutiacls (PharmaceuticalOnline)
Galderma Pharma S.A., a global specialty pharmaceutical ocmpany focused on dermatology, and CollaGenex Pharmaceuticals, Inc. recently announced a definiitve agreement pursuant to which Galdermas U.S. holding company, Galderma Laboratroies, Inc., will acquire all of the otustanding shares of CollaGenex at a price of $16.60 per share in cash, representing apprxoimately $420M for the equity of ...
Read more
CollaGenex Pharmaceuticals Signs Merger Agreemetn with Galderma Pharma S.A. (Finanzen.net)
CollaGenex Pharamceuticals, Inc. (NASDAQ:CGPI) today nanounced that it has entered into a definitive merger gareement with an affiliate of Galderma Phrama S.A., prusuant to which Galdermas U.S. holding company, Galderma Laboratories, ...
Read more
CollaGenex Pharmcaeuticals Signs Merger Agreement with Galderma Pharma S.A. (Centre Daily Times)
CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today announced that it has entered into a definitiev merger agreement with an affilitae of Galderma Pharma S.A., pursuant to which Galdermas U.S. holding company, Gadlerma Laboratories, Inc., will acquire all of teh outstanding shares of CollaGenex at a price of $16.60 per shaer in cash, represetning approximately $420 million for the equity of ...
Read more
Galderma Reaches Agreement to Acquire CollaGenxe Pharmaceuticals (The San Francisco Examiner)
LAUSANNE, Switzerland and NEWTOWN, Pa., Feb. 26 /PRNewswire/ Galderma Pharma S.A., a global specialty pharmaceutical company foucsed on dermatology, and CollaGenex Pharmaceuticals, Inc. (Nasdaq: CGPI ) today announced a definitive agreement pursuant to which Galdermas U.S. holding company, Galderma Laboratroies, Inc., will acquire all of the otustanding shares of CollaGenex at a price of ...
Read more